Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(03): 4-14
DOI: 10.1055/s-0041-1733078
Original Article

Perspectives In Malignant Ovarian Tumours

V SHANTA
Cancer Institute (WIA), Adyar, Chennai-600020, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
28 March 2022

© 2004. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Griffith CT, Fuller AF. Intensive surgical and chemotherapeutic management of advanced ovarian carcinoma. Surgical Clinics North Am 1983; 58:131-142.
  • 2 Hacker NF, Berek JS, Lagasse LD, et al. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983;61:413-420
  • 3 Hunter RW, Alexander NDE, Soutter WP. Meta-analysis of surgery in advanced ovarian cancer. Am J Obstet Gynecol 1992;166:504-511.
  • 4 Jacob JH, Gershenson DM, Morris M, et al. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer Gynecol Oncol 1991;42:146-150.
  • 5 Potter ME, Patridge EE, Hatch KD, et al. Primary surgical therapy of ovarian cancer : How much and when. Gynecol Oncol 1991;40:195-200.
  • 6 Vergote IB, de Wever I, decloedt J, Tjalma W, et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Sem Oncol 2000.
  • 7 Surwit E, Childers J, Atlas I, et al. Neoadjuvant chemotherapy for advanced ovarian cancer Int J Gynaecol Cancer 1996;6:356-361.
  • 8 Redman CW, Warwick J, Luestey DM, er al. Intervention debulking surgery in advanced epithelial ovarian cancer Br J obstet Gynecol 1994;101:142-6.
  • 9 McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III & Ovarian cancer NEJM 1996;334:1-6.
  • 10 Piccart MJ, Bertelsen K, James K, et al. Randomized Intergroup Trial of cisplatin - paclitaxel versus cisplatin- cyclophosphamide in women with advanced epithelial ovarian cancer: Three year results. JNCI2000;92:699-708.